Research work · 2017
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma
Johnny Duerinck, Stephanie Du Four, Frank Bouttens, C. Andre, Vincent Verschaeve, Frank Van Fraeyenhove, C. Chaskis, Nicky D’Haene, Marie Le Mercier, Anne Rogiers, Alex Michotte, Isabelle J. Salmon, Bart Neyns
Journal of Neuro-Oncology